Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Sunday, November 18, 2018 · 468,672,178 Articles · 3+ Million Readers

Global Point of Care Testing (POCT) Devices Market Trend, Segmentation, Opportunities and Forecast To 2024

PUNE, INDIA, April 17, 2018 / -- with their unique quality of simplifying the market research study, presents a deep diving study report “Global Point of Care Testing (POCT) Devices Outlook 2024”

Point of Care Testing (POCT) Devices


The point of care testing (POCT) device in healthcare sector focuses on value rather than test volume and reimbursement issues that minimize tests to the optimal point where outcomes won't suffer while cost efficiencies are gained. The global point of care testing (POCT) diagnostics market is estimated to reach USD 20 billion by the year 2024. 

Upcoming technological advancements in smart phones, biosensors, lab-on-a-chip and wearable devices tend to transform the whole spectrum of POCT market. The driving force behind these innovations in healthcare is to provide ease of diagnosis where the patient is seen at home. In future POC can be the part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine. 

Click here for sample report @


Major Players

Instrumentation Laboratory
International Technidyne Corporation 
Nova Biomedical 
Point of Care Testing (POCT) Devices Major Outlook

On the basis of settings and operating the POCT devices there are two categories: Non professional settings (scenes, non-medical facilities, home, etc) performed by non-traditional operators and professionals settings (Clinics, hospitals, lab, etc) performed by traditional operators. In Mexico, POCT devices are utilized in self monitoring, over the counter and emergency departments. 

One of the driving factor for the growth of POCT devices market is its increasing penetration in developed countries e.g. In most of the European countries like Spain and the UK, the reimbursement system is the reason for augmented demand for POCT devices. The manufacturers are also focusing towards the advancement in point of care devices in terms of design and functionality. 

 Point of Care Testing (POCT) Devices - Competitive Analysis

Key players are making innovative developments in Point of Care Testing (POCT) Devices.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Point of Care Testing (POCT) Devices – Scope

Diabetes represents 67% of the market share and is the primary driver of POCT market followed by other highly growing segments include cardiac coagulations, infectious disease and blood gas with great optimization of care processes. MDx based tests for infectious diseases such as MRSA and Sepsis have significant growth potential as they are POC oriented. 
• Due to multiple testing platforms and manual POCT methods, possibility of complexity of data management and oversight rises. The Philippines and Taiwan are planning national guidelines for POCT. 
• Investment costs for a single POCT assay systems may seem low but POCT devices are limited to one or few assays only and do not produce a fraction of results during their life cycle compared with instruments in the core laboratory. 


For Detailed Reading Please visit @

 About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire